Blog

How Quantitative Systems Pharmacology Addresses Key Challenges in Alzheimer’s Drug Development

Quantitative Systems Pharmacology (QSP) helps address key challenges in Alzheimer’s disease drug development, including tau…

CertaraFebruary 2, 2026

Guide

Seeing is Understanding: Best Practices for Visualizing Nonclinical Study Data

SEND data visualization: best practices for visualizing nonclinical study data to reveal trends, spot outliers,…

CertaraFebruary 2, 2026

Press Coverage

Opinion: To Accelerate Rare Disease Progress, Take a Sandbox Approach

Explore how a collaborative “sandbox” approach—combining flexible regulation, data modeling, and stakeholder engagement—can transform rare…

CertaraJanuary 30, 2026

On-Demand Webinar

Modeling Population PK with Power, Speed, and Ease-of-Use (Phoenix® NLME & Pirana®)

Discover population PK modeling made faster and easier with Phoenix NLME and Pirana in this…

CertaraJanuary 30, 2026

Conference

AI in Drug Discovery 2026

CertaraJanuary 30, 2026

Blog

P21 Enterprise Expands Regulatory Validation Capabilities with Support for the Tobacco Implementation Guide v1.0

Pinnacle 21 supports TIG v1.0, the CDISC Tobacco Implementation Guide for FDA CTP, enabling automated…

CertaraJanuary 30, 2026

Press Release

Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2026

Radnor, Pa. — January 29, 2026 -- Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraJanuary 29, 2026

Blog

Certainty Discovery. Frankfurt, November 4-5, 2025

Certainty Discovery 2025 review by Wendy A. Warr - Vibes, topics and key takeaways.

CertaraJanuary 29, 2026

On-Demand Webinar

Regulatory-Trusted Software for Smarter PK/PD Workflows (Phoenix WinNonlin®)

This on demand session demonstrates how Phoenix WinNonlin® and other tools work together within Phoenix®…

CertaraJanuary 27, 2026

Announcement

Chemaxon discontinues support for various file formats across product portfolio

Chemaxon discontinues support for various file formats across product portfolio in future releases.

CertaraJanuary 27, 2026

How Quantitative Systems Pharmacology Addresses Key Challenges in Alzheimer’s Drug Development

Seeing is Understanding: Best Practices for Visualizing Nonclinical Study Data

Opinion: To Accelerate Rare Disease Progress, Take a Sandbox Approach

Modeling Population PK with Power, Speed, and Ease-of-Use (Phoenix® NLME & Pirana®)

AI in Drug Discovery 2026

P21 Enterprise Expands Regulatory Validation Capabilities with Support for the Tobacco Implementation Guide v1.0

Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2026

Certainty Discovery. Frankfurt, November 4-5, 2025

Regulatory-Trusted Software for Smarter PK/PD Workflows (Phoenix WinNonlin®)

Chemaxon discontinues support for various file formats across product portfolio

Newsletter sign up

Quick links

Solutions

Contact